MOBERG PHARMA

Serial Number 86244304
Registration 5617625
710

Registration Progress

Application Filed
Apr 7, 2014
Under Examination
Feb 17, 2015
Approved for Publication
Dec 23, 2014
Published for Opposition
Dec 23, 2014
Registered
Nov 27, 2018

Basic Information

Serial Number
86244304
Registration Number
5617625
Filing Date
April 7, 2014
Registration Date
November 27, 2018
Published for Opposition
December 23, 2014
Cancellation Date
June 6, 2025
Drawing Code
3

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Jun 6, 2025

Rights Holder

Moberg Pharma AB (publ)

09
Address
Gustavslundsvägen 42, 5tr
Bromma SE-16751
SE

Ownership History

Moberg Pharma AB

Original Applicant
09
Bromma SE

Moberg Pharma AB (publ)

Owner at Publication
09
Bromma SE

Moberg Pharma AB (publ)

Original Registrant
09
Bromma SE

Legal Representation

Attorney
Felicia G. Traub, Esq.

Application History

50 events
Date Code Type Description
Jun 6, 2025 C8.. O CANCELLED SEC. 8 (6-YR)
Nov 27, 2023 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 11, 2021 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 11, 2021 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 11, 2021 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 27, 2018 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 26, 2018 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 25, 2018 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 1, 2018 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 1, 2018 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 26, 2018 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 5, 2018 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2018 GNRT O NON-FINAL ACTION E-MAILED
Apr 5, 2018 CNRT W SU - NON-FINAL ACTION - WRITTEN
Mar 27, 2018 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2018 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 21, 2018 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Feb 17, 2018 IUAF S USE AMENDMENT FILED
Feb 17, 2018 EISU I TEAS STATEMENT OF USE RECEIVED
Nov 2, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 12, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 11, 2017 EX5G S SOU EXTENSION 5 GRANTED
Aug 8, 2017 EXT5 S SOU EXTENSION 5 FILED
Aug 8, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 9, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 7, 2017 EX4G S SOU EXTENSION 4 GRANTED
Feb 7, 2017 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 7, 2017 EXT4 S SOU EXTENSION 4 FILED
Feb 7, 2017 EEXT I SOU TEAS EXTENSION RECEIVED
Sep 3, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 2, 2016 EX3G S SOU EXTENSION 3 GRANTED
Aug 31, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Aug 9, 2016 EXT3 S SOU EXTENSION 3 FILED
Aug 9, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 17, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 15, 2016 EX2G S SOU EXTENSION 2 GRANTED
Feb 15, 2016 EXT2 S SOU EXTENSION 2 FILED
Feb 15, 2016 EEXT I SOU TEAS EXTENSION RECEIVED
Dec 22, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 22, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2015 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 20, 2015 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 20, 2015 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 22, 2015 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 20, 2015 EX1G S SOU EXTENSION 1 GRANTED
Jul 20, 2015 EXT1 S SOU EXTENSION 1 FILED
Jul 20, 2015 EEXT I SOU TEAS EXTENSION RECEIVED
Feb 17, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 23, 2014 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 23, 2014 PUBO A PUBLISHED FOR OPPOSITION

Additional Information

Design Mark
The mark consists of words "MOBERG PHARMA" with an irregular geometrical shape composed of an unbroken curved line which crosses itself several times to create four separated areas of varied shapes and sizes.
Color Claim
Color is not claimed as a feature of the mark.

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"PHARMA"